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Abstract
This chapter describes how bovine amniotic membrane could be indicated for 
wound healing, especially in complex surgery such as urethral reconstruction. 
Chemical studies have assessed both histologically and immunohistochemically that 
bovine amniotic membrane creates scaffold for wound healing. Whereas, clinical 
studies have shown that bovine amniotic membrane property could be substituted 
for wound dressing hence improving skin or mucosal integrity. Bovine membrane 
has been known to be used for many specialties such as ocular surgery, neurosur-
gery, maxillofacial and orthopedic surgery. This chapter includes such studies and 
shows the usage possibility of bovine amniotic membrane for other complex defect 
as shown in urethral reconstruction.
Keywords: bovine amniotic membrane, scaffold, urethral reconstruction, wound 
healing
1. Introduction
Fetal development in mammals is a complex pathway which occurs after prenatal 
embryonic development [1]. Fetal development system is achieved by meticulous 
interactions consisting in umbilical cord, amniotic fluid and placenta. Fetal membrane 
is part of the system, composed of two layers: an outer layer (chorion), which contacts 
maternal cells and an inner layer (amniotic membrane; AM). Fetal membrane holds 
important role in fetal development, essential for protection, breathing, nutrition and 
excretion. Amniotic membrane or amnion is a thin membrane on the inner side of the 
placenta forming a sac that completely surrounds the embryo/fetus and delimits the 
amniotic cavity, which contains amniotic fluid [2, 3]. AM holds important metabolic 
roles by transporting water, other soluble materials and the production of bio-active 
factors, including vasoactive peptides, growth factors and cytokines. AM also provides 
the fetus with protection against dessication and environment of suspension, thus pro-
moting embryonal growth. This function is mainly attributed by tractional resistance 
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mainly related to the condensed layer of interstitial collagen type I, II and elastin [2, 4]. 
Toda et al. mentions that amnion also holds pluripotent differentiation ability with low 
immunogenicity and anti-inflammation property [5]. These properties creates oppor-
tunities and interest on the use of amniotic membrane for regenerative medicine.
The usage for human amnion as a surgical material for skin substitute was first 
suggested and reported by Davis in 1910. Sabella in 1913 performed the first human 
trial for skin grafting [6–8]. Bovine amnion first use for absorbable insulating mate-
rial and suture material was described by Johnson in 1937. Bovine amniotic membrane 
(bAM) and bovine allantoic membrane was suggested as biological dressing [9]. A 
study by Rao stated that further preliminary experimental study using bovine amnion 
xenograft was suggested by Silvetti et al. in 1957 [6]. Since then, there are many basic 
and clinical researches regarding usage of bovine amnion on regenerative medicine.
Bovine amnion was worth noting, due to its wide surface area compared with 
human amnion (6000–7500 sq. cm vs. 1600 sq. cm) and similar histological appear-
ance. Both amnion characteristic is marked with single layer of cuboid epithelium 
[6]. Consideration should be taken for the AM harvest timing due to morphologi-
cal change during gestational period. Morphological change of bovine amniotic 
membrane has been observed between 40 and 230 days of gestation. The epithe-
lium changes from a single layer of flattened, squamous cell containing conspicuous 
cytoplasmic organelles into single or multi-layered cuboidal cells with numerous 
microvilli. This epithelium is further supported by a basement membrane rich 
in collagen. The extracellular matrix is infiltrated with fibroblasts, mesenchymal 
stromal cells, and tissue macrophages (“Hoffbauer cells”) [10].
Proteomic profile of bovine amniotic membrane is proved rich in proteins and 
signaling pathways. An analysis study by da Silva in 2021 identified 2105 proteins 
with an interactive network of 1271 nodes (proteins) and 8757 edges (interactions), 
some of which are known to be present in healing pathway. Notable proteins such 
as albumin, actin, collagen, fibronectin, histone, protein s100, vimentin, tubulin 
are abundant in its composition [11, 12]. Epithelial cell in amniotic membrane also 
secretes several growth factors and cytokines such as epidermal growth factor, 
vascular endothelial growth factor, keratinocyte growth factor, basic fibroblast 
growth factor, transforming growth factors alpha and beta (TGF-a and TGF-b), 
interleukin-8 (IL-8), angiogenin, dipeptidyl peptidase IV (DPPIV/CD26), serine 
protease inhibitor (serpin) E1, also known as type 1 plasminogen activator inhibitor 
(PAI-1), and insulin-like growth factors [3, 13–16].
2.  Bovine amniotic membrane role in regenerative medicine and wound 
healing
Regenerative medicine is a branch of medicine concerned with developing thera-
pies that regenerate or replace injured, diseased, or defective cells, tissues, or organs 
to restore or establish function and structure [17]. Regenerative medicine has 
become an integrated part in medicine and surgery. It has brought potential therapy 
possibilities with the aim to restore and improve the function of the damaged tissue 
or organ [18, 19]. There are many approaches to regenerative medicine, including 
stem cell, tissue engineering, organ transplantation and biomaterials. Biomaterials 
are either synthetic or natural material that are used for medical purpose or in 
contact with biological system. Biomaterials in regenerative medicine are intended 
to facilitate repair mechanism of wound. Usage of biomaterials in wound healing is 
applied on biological dressing. Biological dressing prevents evaporative water loss, 
heat loss, protein and electrolyte loss, and contamination and also permit debride-
ment and develop granulation and epithelialization of wound bed [20].
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Due to its structure as fetal ectoderm, amnion is considered as a physiological 
biological dressing [2, 3]. Amnion is favored due to optimal barrier against bacte-
rial colonization and prevention of water loss [21]. Several studies on burn patients 
showed rapid epithelization of wound bed with minimal graft loss [21–23].
Ideally, the graft should be harvested from the same species (allograft). 
However, human amniotic membrane harvesting has several limitations. Fresh 
amnion is proposed to carry several infectious diseases such as hepatitis, AIDS, 
syphilis and tuberculosis [22]. There are also several difference for each amnion 
harvested from the same donor. The thickness is different at various site of mem-
brane. The thickness could vary from 0.02 to 0.5 mm. This pattern also relates to 
its transparency and translucency of the membrane. Multiple attempts from the 
harvest also creates different thickness from donor harvested near the placenta and 
another distant from it [24, 25]. Differences acquired from different donors are sug-
gested to be contributed from racial variation, duration of gestation, parity, gravid-
ity, labor term and trial of labor before caesarian section. These factors influence 
prostaglandin and pro-inflammatory cytokines when transplanted to the recipient 
[24]. Difficulties in finding donor, long time storage issue also limits the supply [26]. 
Freeze dried human AM is proposed to be the solution for storage issue. Thomson 
and Parks in between 1979 and 1980 had studied the preparation of human amnion 
using sodium hypochlorite 0.025% solution and storaged it at −80° Celcius. There 
was no negative impact on its clinical benefits [23]. However, legal and religious 
issues still limit the supply of human amniotic membrane. Bovine amniotic mem-
brane was proposed to help these shortcomings, providing stable supply.
Wound healing is characterized by sequential phases of inflammation, prolifera-
tion and remodeling [26, 27]. This process is mediated by many cytokines, growth 
hormones, and other mediators. Several numbers of studies were conducted resulting 
that bovine amniotic membrane may exert its therapeutic effects from inflam-
mation to scarring process. Amniotic membrane contains proteinase inhibitors 
which inhibits migration of polymorphonuclear leucocyte cell to wound bed [28]. 
Polymoprhonuclear cell is one type of neutrophils that is extremely active on wound 
healing. Activated neutrophils produce several protease which help killing and degrad-
ing microbes. Neutropil-activated protease also breaks down extra-cellular matrix that 
in turn can debride the wound and facilitate cell migration. Nevertheless, excessive 
amount of neutrophils has negative impact on wound healing, by causing further 
tissue damage and inflammation [29]. A study by Kim et al. showed less polymo-
prhonuclear cell infiltration on amnion-membrane covered group thus promoting 
rapid healing and inhibiting proteolytic damage [30]. Another study by by Shimmura 
et al. proved that amniotic membrane attracts and traps inflammatory cells such as 
monocyte/macrophage, CD4(+) T cell and CD8(+) T cell which are responsible for cell 
apoptosis [31].
Bovine amniotic membrane also contributes on proliferation phase of wound 
healing. Abundant growth factors found on its membrane are responsible for the 
stimulation of proliferation [32]. Epidermal growth factor for instance works 
during proliferation phase (from day 4 postoperative) and promotes wound heal-
ing by increasing the rate of epidermal proliferation and also accelerating wound 
contraction level related to myofibroblast proliferation and collagen deposition [33]. 
Insulin growth factor, combined with Platelet derived growth factor and fibroblast 
growth factor increases the proliferation of fibroblast [34]. Fibroblast is crucial 
on wound proliferation by creating extracellular matrix and collagen structure for 
wound bed, as well as contracting the wound. Once fibroblast has migrated into the 
matrix, it changes its morphology and synthesize granulation tissue components 
[35]. amniotic membrane also has anti-bacterial peptides which makes it ideal for 
cell proliferation. Expression of inflammatory molecule suggested that amniotic 
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membrane is one part of the barrier to progression of infection [36, 37]. Bovine 
amniotic membrane collagen formation is also similar to human amnion according 
to its viability, diffusion formation and degradation [38].
Proliferation phase is also characterized by angiogenesis, granulation and epithe-
lization. Each of these steps could also be influenced by amnion application. Matrix 
metalloproteinase (MMP) is one of growth factor expressed on amniotic membrane. 
It has been implicated in invasive cellular growth [3, 39]. A study by Jeong et al. 
showed that increased expression of membrane-type matrix metalloproteinase 
enhanced the activation of MMP-2 and invasion and migration of endhotelial cells 
which affect the induction of capillary tube formation [40]. Amnion cells secreted 
substantial amount of angiogenic factors including HGF, IGF-1, VEGF, EGF, 
HB-EGF and bFGF [41]. However, there are some studies about in vitro anti-angio-
genic effects of amniotic membrane. Faraj et al. found that AM conditioned medium 
reduced proliferation and angiogenesis. This result was proposed to be induced by 
thrombospondin and tissue inhibitors of metalloproteinase (TIMP 1) and 2 [42–44].
Amniotic membrane also promotes granulation and epithelization. Analysis 
by Piscatelli et al. from in vitro model showed that wound contraction in fetus was 
influenced by combination of pro-contraction transforming growth factor-ß1 and 
anti-contraction epidermal growth factor [45]. Rapid epithelization was histo-
logicallhy confirmed on bovine amniotic membrane-treated wound with thicker 
collagen bundles. Keratinocyte migration was also observed on wound bed whereas 
immunohistochemistry staining for angiogenesis and fibroblast were consistent for 
proliferation phase [26]. The connective tissue of amniotic membrane contains lam-
inin, fibronectin and collagen, which are the main components of basal membrane. 
A case by Martinez et al. showed that spontaneous epithelization on epidermolysis 
bullosa was completed in seven days [46].
Other notable clinical effects of bovine amniotic membrane observed are anti 
scarring, fluid permeability control and tensile strength property. Anti scarring is 
promoted by anti-inflammation effect of AM and hyaluronic acid found on its mem-
brane [47, 48]. Fluid control on wound healing is essential. Extravasation of fluid 
in wound contributes in creating wound exudate. The exudate is a marker of the 
chronic state of injury. Exudate also creates an environment favorable for bacterial 
proliferation [49]. Amniotic membrane structure remains intact after sterilization. 
Clinical study by Rejzek et al. has reported heat, fluid and electrolyte loss prevention 
by amniotic membrane. Oxygen permeability in amniotic membrane was demon-
strated by Yoshita et al., all contributing to accelerated healing process [50, 51].
3. Application of bovine amniotic membrane in surgery
Coradetti et al. demonstrated that mesenchymal stem cells could be derive from 
bovine amnion. Both amnion and amniotic fluid are capable of differentiating into 
ectodermal and mesodermal lineages. This study further showed the capability of 
osteogenic, chondrogenic, adipogenic, and neurogenic stem cell usage for bovine 
amniotic membrane [52]. Thus, bovine amniotic membrane could be used for many 
surgical applications.
4. Ophthalmic surgery
The first use of amniotic membrane for ophthalmology was documented by de 
Rotth back in 1940. The conjunctiva defect caused by symblepharon was treated 
with fetal amniotic membrane. The graft was fixed to the tendon of rectus muscle 
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and was taken in all cases. The study showed that AM has transformation property 
toward conjunctiva tissue [53]. Since then, there have been many applications for 
ophthalmic disease ranging from ocular burn, corneal defects, retinal problems, 
strabismus, and neoplasia. However, most of them used human amnion [54–60].
Proteins expressed on bovine amniotic membrane showed to be abundant in 
human cornea: including keratocan, decorin, lumican, TGF-β-induced protein ig-h3, 
and albumin. These proteins are responsible for corneal healing pathways. Numerous 
signaling pathway responsible for corneal healing are also revealed in the membrane. 
Selected pathways include integrin signaling pathway, Cytoskeletal regulation by 
Rho GTPase, Ubiquitin proteasome pathway, WNT signaling pathway, epidermal 
growth factor (EGF) receptor signaling pathway [11]. Corneal healing was demon-
strated on canine corneal erosion with significantly higher proliferation [61].
5. Plastic and reconstructive surgery
Bovine amnion function as biological dressing holds great potential in recon-
structive surgery. There has been several clinical studies including bovine amnion 
membrane for burn patients [62–64]. Rao published a study in 1981 regarding 
the use of bovine amnion on burn and pressure ulcer patients. The study revealed 
biostatic ability to control infection and faster granulation process [6]. Another 
study by Zhu et al. showed significant difference of burn wound treated with 
bovine amnion compared with vaseline gauze dressing as control. The different 
results studied were healing time, infection ratio and residual burn wound [62]. 
Bovine amnion as burn biological dressing was also proven having similar efficacy 
as human amnion. A study by Park et al. displayed similar histological grading, 
epithelization rate and infection rate [22].
Ablative laser used for removing superficial skin has notable adverse effect even 
though its efficacy is better than non-ablative laser. Adverse effect such as postop-
erative erythema is caused by complete elimination of epidermis and upper dermal 
layer [65]. Bovine amnion membrane was found clinically effective in reducing 
erythema due to its anti-inflammatory mechanism [26].
6. Head and neck surgery
Amnion is also applied in head and neck surgery. Although, some of them used 
human amnion. One of such use was documented as the use of amniotic membrane 
compared with collagen membrane, in a study conducted by Munoyath consisted 
of twenty patients with facial soft tissue injury with whom all patients had either 
single or multiple soft tissue loss all over the face. The size of the wounds ranged 
from 7 mm × 10 mm to 80 mm × 150 mm and depth of the wound ranged from 2 
to 5 mm. the results showed pain score of greater than 3 was observed in 50% of 
the patients in Amnion group and in 80% of the patients in Collagen group. The 
average time for appearance of healthy granulation tissue over the wounds that 
were treated with Amnion dressing was 5 to 9 days and for Collagen group was 7 to 
12 days. Though vascularity was not compromised in both the groups, the height of 
the wound at 3-month follow up showed a clinically significant difference (100% 
patients in AM group had flat wound whereas only 80% showed normal wound 
height); though statistically not significant [66].
In recent years, research of amniotic membrane in head and neck surgery, espe-
cially bovine amniotic membrane, has increased. The use mostly relates to wound 
dressing. Further research could evaluate the use of bovine amniotic membrane 
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in head and neck surgery in the years to come. The amniotic membrane compared 
with collagen membrane, with both materials combined with deproteinized bovine 
bone mineral was compared in clinical trials by Kim for the treatment of periodon-
tal inflammations. Both the use of amniotic membrane and collagen membrane 
combined with deproteinized bovine bone mineral improves the condition of 
periodontium. The amnion did not cause a significant gum recession. Another use 
of amniotic membrane for oral cavity problem was studied for temporomandibular 
joint ankylosis, which is a serious condition, mainly due to injuries responsible for 
the reduction of mandible functionality [67, 68].
A bovine amniotic membrane study for facial abrasions was done in a Korea, 
comparing the use Amnisite BAtm with foam and gel dressings. The study dem-
onstrated all patients were well healed completely after appliance of dried bovine 
amniotic membrane or foam dressing without any complication. However healing 
time for patients treated with dried bovine amniotic membrane was significantly 
shorter and no significant difference between the two groups regarding treatment 
costs, scar formation, skin elasticity or moisture content was noted. This study 
demonstrate the potential practical clinical use of bovine amniotic membrane as a 
facial soft tissue trauma as one of potential dressing [69].
7. Neurosurgery
In the field of neurosurgery, autologously harvested amniotic membrane has 
been used to repair duramater defects in myelomeningocele. Although the human 
cranial neurosurgery applications of amniotic membrane have not been thoroughly 
investigated, an in vivo rat cranial surgery model demonstrated that human xenograft 
amniotic membrane was efficacious and had an adequate safety profile. Eichberg put 
forward their retrospective pilot study about the use of allograft amniotic membrane 
for the augmentation of dural repair in craniotomies. The reported rates of postopera-
tive CSF leaks differ among studies and craniotomy locations; leaks may prevailed as 
many as 4–17% craniotomy for posterior fossa lesions. In 122 craniotomies, including 
18 craniotomies for posterior fossa lesions, none were complicated by postoperative 
CSF leaks. These results suggest that amniotic does not contribute to the increased 
risk of CSF leaks. Further, the interpretation of the data is complicated by the fact 
that the patients in the study received a sheet of bovine collagen dural substitute 
layered on top of the dehydrated amnion membrane; thus, the outcomes may be due 
to both materials. While this retrospective pilot study does not prove the superiority 
of dehydrated amnion over other dural adjuncts, or the efficacy of use, they demon-
strate that it has an adequate safety profile with no complications directly related to its 
use in closures for craniotomies. They also report very low CSF leak rates and infec-
tion rates, particularly in craniotomies for infratentorial lesions [70–72].
8.  Pediatric urology: the prospect of urethral reconstruction using 
bovine amniotic membrane
In the field of urology or pediatric surgery, uroepithelial reconstruction for several 
pathology is challenging. There is no synthetic material that is considered ideal as a sub-
stitute for the urethra and there is no research that firmly determine a good synthetic 
material to replace urethral defects. Strictures still found after the transplantation of 
acellular scaffold was also reported [73]. Therefore, the use of cell-seeded scaffold 
is proposed to be a better material used in urethral reconstruction. Bovine amniotic 
membrane has unique properties including anti-adhesive effects, bacteriostatic 
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properties, wound protection, pain reduction, and epithelialization effects. Another 
characteristic of amniotic membrane is the lack of immunogenicity [26].
Amniotic membrane also has some advantage compared to other allographs, 
such as bladder mucosa, buccal mucosa, and also appendix tissue. First of all, 
amnion harvesting does not need extra surgery unlike other organ. Postoperative 
care is simpler with shorter hospital time. However, there is technical difficulty in 
handling the membrane. Due to the thinness of the amniotic membrane and the 
release of the amniotic layer to the chorion, there is a higher risk of perforation or 
tear or separation of the two layers during surgery [74].
Bovine amniotic membrane has been studied mostly on animal studies with prom-
ising effects. One experimental study for urinary bladder reconstruction by Bakhtiari 
in 2000 was using fresh and formalin based bovine amniotic membrane for canine. 
Urinary bladder and urethra share similar histology. Both are consisting of epithelium 
on the lumen surrounded by rich collagen connective tissue and muscle layer. Both are 
responsible for maintaining structural integrity of the organ and transporting or expel-
ling the urine [75]. The surgical procedure was conducted by 5 cm resection from the 
cranial bladder. Postoperative graft using two types of bovine amniotic membrane was 
observed. Graft site observations on postoperative days 30 and 60 showed adhesion at 
the graft site (100%), the graft floating within the bladder lumen (40%), good graft 
adhesion to the bladder, and no evidence of leakage or fistulation. Histopathological 
examination revealed regeneration of uroepithelial tissue and smooth muscle at the 
graft site. In addition, congestion, edema, and inflammatory cell infiltration were also 
seen in two cases. According to this study, despite complications such as infection, 
release of amnion from the bladder, “less than normal” distension and adhesions of the 
bladder at the graft site, it can be argued that fresh and preserved bovine amnion acts as 
a scaffold for the repair of canine bladder defects. The regeneration of the urothelium 
and the presence of microscopic smooth muscle and the important complications that 
may occur from enterocystoplasty can encourage the use of bovine amniotic membrane 
for bladder reconstruction. However, long-term studies are still needed to assess other 
clinical and laboratory findings before measuring for clinical use [76].
In another study, Shakeri demonstrated the ability of the human amniotic mem-
brane to induce epithelialization in experimental study on rabbits by reconstructing 
the urethra using the human amniotic membrane. The evaluation was conducted 
after 30 days post-operative. The result showed re-epithelialization of urethral 
without inflammation and tissue loss. The author also concluded that amniotic 
membrane is an inexpensive, easy, and biodegradable graft with very little antigen 
effect which seems to be the ideal solution for urethroplasty [74].
Amniotic membrane could be used as potential source for stem cell. Ghionzoli 
and Chung showed that it could be differentiated into smooth muscle and urothe-
lial cell, both which are becoming integral parts creating urethral tissue [77, 78]. 
Despite using human amniotic membrane, some preclinical studies have also 
explored urological applications. Iijima demonstrated that amniotic membrane 
could successfully be used for bladder augmentation in rats. Human amniotic 
membrane-augmented bladder revealed regeneration of urothelium, detrusor 
smooth muscle, and nerve fibers within 3 months post-operatively. Bladder capacity 
was also found to be normal within 4 weeks post-operatively [79].
Pusateri evaluated placental membrane grafts for urethral replacement in rabbit 
model. The procedure consisted of mobilitation of urethra, dorsal urethrotomy and 
graft placement. Dorsal onlay urethroplasty was performed afterwards. Observation 
after 3 month showed urethral patency in all rabbits. On pathologic examination, 
urothelial cell replacement was observed in all rabbit without malignant transforma-
tion. Urothelium was intact and circumferentially normal in all sections of graft bed. 
On cystourethroscopy, there was no strictures, fistulas or massess reported [80].
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Wang et al. looked further to this idea, namely using the collagen scaffolding of 
amniotic membrane as potential regenerative material in urethroplasty. The authors 
separated basement layer of amnion to retrieve denuded human amniotic scaffold. 
Rabbit urethral epithelial cell was inoculated on its surface and the response showed 
mild immune reaction with no rejection. This maximizes the biocompability of amni-
otic membrane making it potential biomaterial for urethral reconstruction [81]. Gunes 
took another approach by combining amniotic membrane and buccal mucosa for penile 
urethral reconstrucion in rabbit model. Both membrane were obtained from rabbit. 
Gunes compared whether buccal mucosa, amniotic membrane or both might be useful 
in urethroplasty. The best result of epithelial transformation was shown in combined 
group after 8 weeks with no complication regarding fistula or dehiscence observed [82].
Hariastawa et al. compared both bovine and human amniotic membrane for 
reconstruction of urethral defect in rabbit animal model. His study aimed to 
discover the difference in mucosal integrity between both groups. Epithelium 
layer was formed in both group with no significant ddifference of postoperative 
mucosal grading on day 7,14 and 28 postoperatively. Authors concluded that bovine 
amniotic membrane could be used as good, cheap alternative in urethral defect 
reconstruction [83]. In another study, Hariastawa used dried amniotic membrane 
scaffold with adipose derived-mesenchymal stem cell seeding for rabbit penile ure-
thral reconstruction. Adipose cell was cultured from rabbit neck and mixed with 
fetal bovine serum. Viability of stem cell was tested before the surgical procedure. 
The urethral wall was cut transversely before the scaffold that had been seeded 
with stem cells was implanted as urethral graft. Urethroplasty was done afterwards. 
Post-operative clinical observation showed urethral integrity alongside the defect. 
Urethral specimen was harvested on day 28 post-operatively. The specimen was 
then observed using fluorescene microscope. Neovascularization and best epithe-
lial transformation was seen in combined amniotic membrane and adipose-derived 
mesenchymal stem cell seeding group. The promising result showed that stem cell 
could be used as adjunct treatment for amniotic membrane application [84].
Although limited to human amniotic membrane, clinical researches have been 
accepted. The first clinical report regarding the use of human amniotic membrane 
for anterior urethral defect repair was reported by Razzaghi et al. This pilot study 
included patients with previous hypospadia repair [85]. Hypospadias repair remains a 
challenge due to many anatomical variation of the pathology, surgical techniques and 
comorbidities of patient. Complications vary from dehiscence, stenosis to fistula for-
mation. Secondary or salvage procedure were often needed for failed primary repair 
[86, 87]. After reconstruction of neourethra and proper hemostatis from urehtroplasy, 
the allograft was used to cover the suture lines. Observation between 7 to 18 moths 
post-operatively showed no long term complications. Amniotic membrane graft was 
proposed as an applicable, low-cost, biodegradable cover for second hypospadias 
repair [85]. Oottamasathien et al. proposed that amniotic membrane could be used for 
reducing complication rate, particularly from high re-operation rate of hypospadias. 
The underlying premise is to provide a barrier layer with robust source of tissue, vas-
cular growth factors and anti-inflammatory environment for soft tissue healing [88].
9. Summary
Potential future application of bovine amniotic membrane could be explored 
widely. Broad number of biological properties found in amniotic membrane 
described above presents future studies. Preclinical and clinical researches could 
be used for basic scaffold for other applications. Combination with other biomate-
rials would be considered further.
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